EGFR and lung cancer: Previous studies mainly used the clinical characteristics, conventional metabolic parameters, and radiomics features of 18F-FDG PET/CT to predict EGFR mutation status in patients with lung cancer, such as tumor margin, CEA level, smoking history, and SUVmax (35).